ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Clinical trial NCT03903835 · RECRUITING

Trial details

NCT number: NCT03903835
Sponsor: Karolinska Institutet
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Start date: 2019-02-01
Primary completion: 2026-12-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.